TPST
Tempest Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
−3.86%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.32
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.30
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -4.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.30 | -$0.34 | Miss -13.33% | — |
| May 15, 2026 | -$0.28 | -$0.51 | Miss -82.14% | — |
| Mar 30, 2026 | -$0.62 | -$0.62 | In line | — |
| Nov 5, 2025 | -$3.27 | -$0.79 | Beat 75.84% | — |
| Mar 27, 2025 | -$3.12 | -$4.03 | Miss -29.17% | — |
| Aug 8, 2024 | -$6.11 | -$5.46 | Beat 10.64% | — |
| May 9, 2024 | -$5.72 | -$4.68 | Beat 18.18% | — |
| Mar 19, 2024 | -$4.94 | -$4.42 | Beat 10.53% | — |
| Aug 10, 2023 | -$7.54 | -$7.02 | Beat 6.90% | — |
| Mar 22, 2023 | -$9.36 | -$8.19 | Beat 12.50% | — |
| Aug 15, 2022 | -$12 | -$10 | Beat 14.13% | — |
| May 13, 2022 | -$15 | -$15 | Miss -5.36% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026